Stage III Colorectal Adenocarcinoma: Meagan's Survivor Story

Patient Info: Meagan, Female, Under 40 | Stage III

In remission after surgery and 6 months of FOLFOX for high-risk Stage IIIC sigmoid colon adenocarcinoma, with ongoing 6-month scan monitoring and survivorship challenges including scanxiety and neuropathy.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Kalei's Patient Story

Patient Info: Kalei, Female | Stage IV

Metastatic Site: Lungs

Living with Stage IV rectal cancer after lung metastases were treated surgically; later imaging raised concern for possible recurrence in the lung and rectal area, but lymph-node biopsy was clear and further workup was ongoing.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Joe's Patient Story

Patient Info: Joe, Male | Stage IV

Biomarkers: Specific biomarkers not reported

Metastatic Site: Liver; lymph nodes; lungs

Stage IV colon cancer initially reached no evidence of disease after FOLFOX plus panitumumab, but later recurred in the liver and lymph nodes, progressed to the lungs, and did not respond to later FOLFOX rechallenge or FOLFIRI before he started an immunotherapy clinical trial.

The Patient StoryRead more →

Stage IV Non-Small Cell Lung Cancer: Natalie's Patient Story

Patient Info: Natalie, Female, Under 40 | Stage IV

Metastatic Site: Spine

Natalie was living with Stage IV NSCLC after a double lung transplant gave her new lung function, but cancer later appeared in the spine and required renewed chemotherapy and radiation.

The Patient StoryRead more →

Stage III Colorectal Cancer: Amber's Survivor Story

Patient Info: Amber Mike, Female, 40s | Stage III

As of February 2026, Amber had completed Stage III colorectal cancer treatment, was doing well under close monitoring with tumor markers every 3 months, and was rebuilding life through survivorship, therapy, travel, and advocacy.

City of HopeRead more →

FAP-associated desmoid tumor after prior rectal cancer: surveillance with tumor shrinkage

Patient Info: Anonymized, Female, 40s

Biomarkers: APC p.Cys607Ter mutation; beta-catenin positive; Ki-67 about 2%. Other diagnostic markers supported desmoid tumor.

At 5-year follow-up, CT showed more than 50% tumor shrinkage, reduced organ compression, complete resolution of mesenteric ischemia signs, partial symptom relief, and no malignant polyps on annual colonoscopy.

PubMed CentralRead more →

Stage I EGFR Lung Cancer: Shira's Survivor Story

Patient Info: Shira, Female | Stage I

Biomarkers: EGFR exon 20 insertion

Shira had Stage IB lung cancer detected early through imaging and treated with surgery alone. Her tumor was later categorized as low risk of recurrence, and she described herself as cancer-free as of February 2026.

The Patient StoryRead more →

Stage I Colorectal Cancer: Timothy's Survivor Story

Patient Info: Timothy Beckner, Male, 40s | Stage I

As of February 2026, Timothy was cancer-free after laparoscopic surgery for Stage I cecum/right-sided colon cancer and was moving into surveillance colonoscopy follow-up.

Cleveland ClinicRead more →

Stage III Colorectal Cancer: John's Survivor Story

Patient Info: John Murray, Male, 50s | Stage III

As of February 2026, John’s latest tests showed no evidence of cancer after Stage III rectal cancer treatment, including chemotherapy, radiation, and laparoscopic surgery with permanent colostomy; close surveillance was planned for 2 years.

Cleveland ClinicRead more →

Stage I Lung Cancer: Taylor's Survivor Story

Patient Info: Taylor, Female, Under 40 | Stage I

Taylor had a Stage IB 4 cm lung carcinoid tumor removed surgically with clean margins at age 21. She did not need chemotherapy or radiation and was 18 years post-diagnosis as of February 2026.

The Patient StoryRead more →

Stage IV Small Cell Lung Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Robertson, Female, 40s | Stage IV

Metastatic Site: Collar bones; shoulder blades; femur; pancreas;…

As of February 2026, Jennifer had shown no evidence of disease since August 2025 after tarlatamab-dlle and whole-brain radiation, while continuing tarlatamab infusions every other Monday and scans every 3 months.

MD AndersonRead more →

Stage IV Colorectal Cancer: Phil's Survivor Story

Patient Info: Phil Bosanko, Male, 40s | Stage IV

Metastatic Site: Liver

As of February 2026, Phil was alive and cancer-free nearly 20 years after a Stage IV colon cancer diagnosis with extensive liver metastases.

City of HopeRead more →

Stage IV Lung Cancer treatment and follow-up story

Patient Info: Tina Powell, Female | Stage IV

As of January 2026, Tina was 3 years into Stage IV lung cancer, on a clinical trial at Memorial Sloan Kettering, and undergoing CT chest, CT pelvis, and brain MRI every 6 weeks.

YouTube (JA search)Read more →

I Survived Childhood Cancer. Then I Was Diagnosed AGAIN at 18.

Patient Info: Maria, Female, Under 40

Biomarkers: Mosaic variegated aneuploidy syndrome 3; prior colon polyp genetic testing negative before final diagnosis

The early colon cancer was removed during colonoscopy, but Maria continues long-term surveillance for recurrent polyps and survivorship effects related to childhood Wilms tumor and MVA3.

The Patient StoryRead more →

ALK-positive inflammatory myofibroblastic lung tumor: surgery and 2-year recurrence-free surveillance

Patient Info: Anonymized, Female, 60s

Biomarkers: ALK-1-positive; TPM4-ALK rearrangement; TP53 missense variant VAF 2.3%; DNMT3A frameshift mutation VAF 2.3%

She remained stable without recurrence for 2 years after complete surgical resection of an ALK-positive inflammatory myofibroblastic tumor of the lung.

PubMed CentralRead more →

Stage III Colorectal Cancer: Briana's Survivor Story

Patient Info: Briana, Female, Under 40 | Stage III

A CT scan before completion of chemotherapy showed no signs of disease; she later had colostomy reversal and returned to work and normal activity while continuing scan surveillance.

The Patient StoryRead more →

Stage III MSI-High Colorectal Cancer: Tommy's Survivor Story

Patient Info: Tommy Allen, Male, 50s | Stage III

Biomarkers: MSI-high; Lynch syndrome

As of November 2025, Tommy was cancer-free 5 years after pembrolizumab, ileostomy, Whipple procedure, partial colectomy, and ileostomy closure for Stage III MSI-high colon cancer with Lynch syndrome.

MD AndersonRead more →

Stage I Invasive Lobular Carcinoma: Tammy's Survivor Story

Patient Info: Tammy, Female, 60s | Stage I

As of October 2025, Tammy had fully recovered and remained disease-free after Stage I invasive lobular breast cancer treated with partial mastectomy and a targeted week-long radiation course, with ongoing follow-up monitoring.

Cleveland ClinicRead more →

Stage II Triple-Negative Breast Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Rancik, Female, Under 40 | Stage II

Biomarkers: BRCA1 mutation; triple-negative breast cancer

Jennifer entered remission in October 2017 after Stage II triple-negative breast cancer treatment and, as of October 2025, reported doing great and being off medications except occasional Zometa.

City of HopeRead more →

The Cancer Spread One Year Later…

Patient Info: Kalei, Female, Under 40 | Stage IV

Metastatic Site: Lungs; bilateral lung nodules

Kalei initially had Stage II rectal cancer that responded to chemoradiation and IV chemotherapy without rectal surgery. In 2025, biopsy-proven lung metastasis changed the diagnosis to Stage IV. As of October 2025, she had undergone lung resections with clear margins and remained in ongoing follow-up rather than having a clearly stated NED status.

The Patient StoryRead more →

Stage II Colorectal Adenocarcinoma: Ali's Survivor Story

Patient Info: Ali, Female, Under 40 | Stage II

Ali completed 8 chemotherapy treatments after delivering her daughter by C-section at 35 weeks. A January 2025 scope and biopsy confirmed remission, and later MRI, scope, and colonoscopy surveillance were good. As of October 2025, she remained on close watch-and-wait surveillance.

The Patient StoryRead more →

Paget disease, bilateral apocrine breast carcinomas, and primary breast follicular lymphoma after aromatase inhibition

Patient Info: Anonymized, Female, 70+

Biomarkers: Initial breast cancer was ER/PR-positive, HER2-negative. Later apocrine cancers were triple-negative with AR/ER-beta markers. Lymphoma had IgH::BCL2.

As of September 2025, she was alive 3 years after bilateral mastectomy and observation for Stage Ie follicular lymphoma, with no recurrence of either breast carcinoma or lymphoma.

PubMed CentralRead more →

Stage I Colorectal Cancer: Jessica's Survivor Story

Patient Info: Jessica, Female, Under 40 | Stage I

Biomarkers: Lynch syndrome

Jessica had Stage I Lynch syndrome-associated rectal cancer treated with an immunotherapy clinical-trial approach rather than chemoradiation or surgery. Midpoint colonoscopy and MRI showed the mass was gone, and she completed 7 infusions over 6 months. As of September 2025, she was in survivorship with intensive Lynch syndrome surveillance.

The Patient StoryRead more →

Stage IV ALK Non-Small Cell Lung Cancer: Steven's Patient Story

Patient Info: Steven Huff, Male, Under 40 | Stage IV

Biomarkers: ALK-positive

Metastatic Site: Lungs; liver; spine; sacrum; chest lymph nodes;…

Steven had Stage IV ALK-positive NSCLC and responded well to twice-daily oral targeted therapy, with several years of stable scans and a return to teaching and family life. As of September 2025, he remained on active treatment rather than being cancer-free.

The Patient StoryRead more →